By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > General > Valproate

Valproate

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|674 words

What is Valproate?

Valproate is an anticonvulsant medication that belongs to a class of drugs called antiepileptic drugs (AEDs). It is primarily used to treat epilepsy, bipolar disorder, and prevent migraine headaches. Valproate has been widely prescribed since the 1970s and is considered one of the most effective broad-spectrum antiepileptic medications available.

Uses

Valproate is approved for several medical conditions:

Epilepsy: Used to control various types of seizures, including absence seizures, tonic-clonic seizures, and complex partial seizures. It is particularly effective for generalized epilepsy syndromes.

Bipolar disorder: Helps stabilize mood and prevent manic episodes in adults with bipolar I disorder. It can be used alone or in combination with other mood stabilizers.

Submit Your Paper
GMJ_Submit_Banner

Migraine prevention: Reduces the frequency and severity of migraine headaches when taken regularly as a preventive treatment.

Acute mania: Used to treat manic or mixed episodes associated with bipolar disorder, helping to control symptoms like elevated mood, racing thoughts, and impulsive behavior.

Off-label uses: Sometimes prescribed for certain psychiatric conditions, neuropathic pain, and other seizure-related disorders under medical supervision.

How it works

Valproate works by affecting neurotransmitter activity in the brain through multiple mechanisms. It increases levels of gamma-aminobutyric acid (GABA), a calming neurotransmitter, while also blocking sodium and calcium channels in nerve cells. These actions help stabilize electrical activity in the brain, preventing seizures and mood episodes.

Side effects

Common side effects:

  • Nausea and vomiting
  • Drowsiness or fatigue
  • Dizziness
  • Weight gain
  • Hair loss or changes in hair texture
  • Tremor
  • Diarrhea
  • Abdominal pain

Serious side effects requiring immediate medical attention:

  • Severe liver damage (hepatotoxicity)
  • Pancreatitis (inflammation of the pancreas)
  • Severe allergic reactions or skin rash
  • Blood disorders (low platelet count, bleeding)
  • Suicidal thoughts or behavior

Warnings and precautions

Pregnancy risk: Valproate carries significant risks during pregnancy, including birth defects and developmental delays. Women of childbearing age should use effective contraception and discuss family planning with their healthcare provider.

Liver function: Regular liver function tests are required, especially during the first six months of treatment, as valproate can cause serious liver damage, particularly in children under two years old.

Blood monitoring: Periodic blood tests are necessary to monitor for blood disorders, including low platelet counts that can increase bleeding risk.

Suicidal ideation: Like other antiepileptic drugs, valproate may increase the risk of suicidal thoughts and behaviors, requiring careful monitoring of mood changes.

Age considerations: Children and elderly patients may be at higher risk for certain side effects and require more frequent monitoring and dose adjustments.

Interactions

Valproate has numerous significant drug interactions:

Warfarin: Valproate can increase bleeding risk by displacing warfarin from protein binding sites and affecting platelet function.

Lamotrigine: Valproate significantly increases lamotrigine levels, requiring substantial dose reductions of lamotrigine to prevent serious skin reactions.

Phenytoin: Complex interaction where valproate can increase free phenytoin levels while total levels may appear normal or decreased.

Carbamazepine: Mutual interaction where both drugs can affect each other’s metabolism, requiring careful dose monitoring.

Topiramate: Increased risk of hyperammonemia and encephalopathy when used together.

Aspirin: Can increase valproate levels by displacing it from protein binding sites, potentially leading to toxicity.

Carbapenem antibiotics: Can dramatically reduce valproate levels, potentially leading to breakthrough seizures.

Alcohol: Increases central nervous system depression and may affect liver metabolism.

Check interactions with the GMJ Interaction Checker

Dosage

Dosage varies significantly based on the condition being treated and individual patient factors. For epilepsy, adults typically start with 10-15 mg per kilogram of body weight daily, divided into two or three doses, with gradual increases as needed. For bipolar disorder, initial doses usually range from 750-1000 mg daily in divided doses. For migraine prevention, doses typically range from 250-1000 mg daily. Blood level monitoring is often used to optimize dosing, with therapeutic levels generally between 50-100 mcg/mL. All dosage decisions should be made by a healthcare provider based on individual patient needs, response to treatment, and blood level monitoring.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Valproate." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/valproate/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
FDA’s Pazdur Calls for Agency Restructuring Amid China Competition and Internal Upheaval

FDA's Rick Pazdur calls for fundamental agency restructuring following internal disruption, citing…

Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access

Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations.…

NHS Patient Watchdog Abolition Sparks Concerns Over Health Service Accountability

Local councils warn that government plans to abolish NHS patient watchdogs will…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Acyclovir

By
Prof. Giorgi Pkhakadze
02/06/2026

Trazodone

By
Prof. Giorgi Pkhakadze
02/06/2026

Paracetamol

By
Prof. Giorgi Pkhakadze
02/06/2026

Acetaminophen

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up